Growth Metrics

LifeMD (LFMD) Cash & Current Investments (2016 - 2025)

LifeMD filings provide 14 years of Cash & Current Investments readings, the most recent being $37.1 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 13.5% to $37.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.1 million, a 13.5% increase, with the full-year FY2025 number at $37.1 million, up 13.5% from a year prior.
  • Cash & Current Investments hit $37.1 million in Q4 2025 for LifeMD, up from $24.2 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $41.5 million in Q4 2021 to a low of $4.1 million in Q4 2022.
  • Median Cash & Current Investments over the past 5 years was $24.9 million (2022), compared with a mean of $24.0 million.
  • Biggest five-year swings in Cash & Current Investments: soared 5494.51% in 2021 and later crashed 90.16% in 2022.
  • LifeMD's Cash & Current Investments stood at $41.5 million in 2021, then crashed by 90.16% to $4.1 million in 2022, then surged by 723.13% to $33.6 million in 2023, then dropped by 2.79% to $32.7 million in 2024, then grew by 13.5% to $37.1 million in 2025.
  • The last three reported values for Cash & Current Investments were $37.1 million (Q4 2025), $24.2 million (Q3 2025), and $36.5 million (Q2 2025) per Business Quant data.